Skip to content

PTC Therapeutics PTCT Business Segments — Segment Reporting Other Item Amount

Similar metrics at other companies

Danaher logo
DHRLife Sciences — Segment Reporting, Other Segment Item, Amount
$1.31B+2.1%
Thermo Fisher Scientific logo
TMOLife Sciences Solutions — Other segment items
$50M+11.1%
Corvex
 logo
MOVESegment Reporting — Segment Reporting Other Item Amount
$1.42M
Rockwell Automation logo
ROKLifecycle Services — Segment Reporting, Other Segment Item, Amount
$1M
Rigetti Computing, Inc. logo
RGTISingle Reportable — Segment Reporting Other Item Amount
-$55.06M+11.7%
Elanco Animal Health Inc. logo
ELANReportable Segment — Segment Reporting, Other Segment Item, Amount
$154M+12.4%

Other financials

Income statement

See full
Revenue$272.6M-76.8%
Operating income$45.0M-95.4%
Net income-$2.8M-100%
EPS (diluted)-$0.03-100%

Balance sheet

See full
Cash & equivalents$834.0M-43.7%
Total debt$395.1M+0.1%
Total equity-$180.5M+2.9%
Total assets$2.9B+8.0%

Cash flow

See full
Operating cash flow-$59.0M-107%
CapEx$1.2M-30.6%
Free cash flow-$60.2M-107%

Valuation

See full
Market cap$6.55B+40.3%
Enterprise value$6.11B+77.3%
P/E
P/S7.9×+5.3×

Profitability

See full
Gross margin96%
Operating margin1.6%-38.7pp
Net margin42.3%+27.4pp
FCF margin39.1%+32.8pp

Returns & leverage

See full
Return on equity-216.7%
Debt / equity372.3×
Current ratio2.4×-1.5×

Where this comes from

Reported directly by PTC Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:SegmentReportingOtherItemAmount.

The official record: PTC Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about PTC Therapeutics's business segments — segment reporting other item amount.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is PTC Therapeutics's business segments — segment reporting other item amount?
PTC Therapeutics (PTCT) reported business segments — segment reporting other item amount of $107.89M in Q1 2026.
How has PTC Therapeutics's business segments — segment reporting other item amount changed year-over-year?
PTC Therapeutics's business segments — segment reporting other item amount decreased by 25.8% year-over-year, from $145.42M to $107.89M.
What is the long-term trend for PTC Therapeutics's business segments — segment reporting other item amount?
Over 3 years (2022 to 2025), PTC Therapeutics's business segments — segment reporting other item amount has grown at a -6.0% compound annual growth rate (CAGR), from $437.41M to $363.61M.
What does business segments — segment reporting other item amount mean?
This captures miscellaneous or non-recurring financial items specific to the life science segment that do not fit into standard operating expense categories. It is used to reconcile segment performance by accounting for unique adjustments, impairments, or one-time charges.